Dietary intake and weight gain of pregnant dams treated with <i>U. simensis</i> essential oil. حسب Bickes Wube (21678222)

الموضوعات:

Implantation and resorption of 20-day old rat fetuses treated with <i>U.simensis</i> essential oil I-implantation, R-resorption, TR-total resorption only in one gravid rat, O-ovary... حسب Bickes Wube (21678222)

الموضوعات:

In vivo development of 12-day old rat embryos treated with <i>U.simensis</i> essential oil: VV – vitelline blood vessels, YS-yolk sac, TE- telencephalon, ME-mesencephalon, PA-phary... حسب Bickes Wube (21678222)

الموضوعات:

Skeletal ossification of alizarin red stained 20-day old rat fetuses treated with <i>U.simensis</i> essential oil: TL-thoracic and lumbar vertebrae, O-occipital bone, MC-metacarpal... حسب Bickes Wube (21678222)

الموضوعات:

All raw data support findings of the study. حسب Bickes Wube (21678222)

الموضوعات:

Comparative Analysis of Chills Experience Across Three Groups: This table presents a detailed comparison of three groups (A, B, and C) in terms of their experiences with chills. It... حسب Felix Alexandre Schoeller (20988295)

الموضوعات:

pRPS6 and proliferation rates of starved Vasa2+/Piwi1+ cells were independent on the daytime of refeeding, and phospho-RPS6 was found in S- and M-phase Vasa2+/Piwi1+ cells. حسب Eudald Pascual-Carreras (12115380)

Two-way ANCOVA results for Task 1. The bold values highlight statistically significant results of Task 1. حسب Mucahit Gemici (21519313)

One-way ANCOVA results for Task 2. The bold values highlight statistically significant results of Task 2. حسب Mucahit Gemici (21519313)

Myeloid knockout <i>VANGL2</i> exacerbates the progression of DSS-induced colitis in mice. حسب Huaji Jiang (16907514)

Down-regulation of VANGL2 in IBD patients triggers overt activation of NLRP3 inflammasome. حسب Huaji Jiang (16907514)

Summary of post-treatment disease course measures from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Study selection criteria. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. حسب Filip Stanicic (17808254)

الموضوعات:

Disease course measures after the PTSD treatments. حسب Filip Stanicic (17808254)

الموضوعات:

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment disease course measures from off-label medications clinical trials. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. حسب Filip Stanicic (17808254)

الموضوعات: